The pioneering company, axial3D is developing an automated 3D printing solution for the healthcare sector which is dramatically advancing the standards and efficiency of surgery worldwide.
The funding round was led by London-based Imprimatur Capital Fund Management, an international science and technology investor. The round was also supported by a US investment consortium consisting of a number of surgical angel investors.
axial3D’s previous institutional investors Techstart Ventures, Clarendon Fund Managers and Innovation Ulster Ltd also participated in the round.
The investment will support axial3D’s rapid growth plans for the USA. The company plans to open an office in the region.
The firm is creating roles within the expanding US market and at its base in Belfast to support the large growth and ensure continuous innovation.